Literature DB >> 24100641

Papillary calcifications: a new prognostic factor in idiopathic calcium oxalate urolithiasis.

Walter Ludwig Strohmaier1, Markus Hörmann, Gernot Schubert.   

Abstract

Metabolic evaluation is not suitable to forecast the course of the disease in idiopathic calcium oxalate stone formation (iCaOxU). An important pathway in CaOx stone formation is the overgrowth on interstitial apatite papillary plaques. Therefore, we studied whether the extent of such plaques may be used as a prognostic factor in CaOxU. Prospectively, we studied n = 100 patients with iCaOxU. For stone analysis, X-ray diffraction/polarizing microscopy was used. During flexible ureteroscopy and flexible percutaneous nephrolithotomy, all the renal papillae were inspected, counted and the severity of calcifications assessed. A calcification index (CI) was calculated: sum of the No. of papillae × calcification grade (1-3) × No. of calcified/total No. of papillae. Furthermore, the following parameters were examined in all patients: age, sex, BMI, arterial blood pressure, stone episodes, DM; blood: creatinine, glucose, uric acid, calcium, sodium and potassium; urine: pH, volume, calcium, uric acid, citrate, ammonia and urea. Using the statistic programme Prism 5 (GraphPad), summary statistics and non-parametric correlations (Spearman) and their significance were calculated. The CI correlated significantly (r = 0.37; p = 0.012) with the No. of stone episodes. Apart from citrate (r = 0.51; p = 0.002), none of the conventional metabolic parameters correlated significantly with the No. of stone episodes. Paradoxically, the citrate excretion-although citrate being an inhibitor of CaOx stone formation-positively correlated to the recurrence rate. The endoscopic assessment of papillary plaques/calcifications and the calculation of the CI are a more suitable prognostic factor in CaOx than conventional metabolic evaluation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100641     DOI: 10.1007/s00240-013-0606-3

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  16 in total

Review 1.  Guidelines on urolithiasis.

Authors:  H G Tiselius; D Ackermann; P Alken; C Buck; P Conort; M Gallucci
Journal:  Eur Urol       Date:  2001-10       Impact factor: 20.096

Review 2.  Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2012-01-04

3.  Oxypurines, protein, glucose and the functional state of blood vasculature are markers of renal calcium stone-forming processes? Observations in men with idiopathic recurrent calcium urolithiasis.

Authors:  Mahimaidos Manoharan; Paul O Schwille
Journal:  Clin Chem Lab Med       Date:  2002-03       Impact factor: 3.694

Review 4.  Epidemiology and medical management of stone disease.

Authors:  H-G Tiselius
Journal:  BJU Int       Date:  2003-05       Impact factor: 5.588

Review 5.  Three pathways for human kidney stone formation.

Authors:  Fredric L Coe; Andrew P Evan; Elaine M Worcester; James E Lingeman
Journal:  Urol Res       Date:  2010-04-22

6.  Factors influencing the course of calcium oxalate stone disease.

Authors:  H G Tiselius
Journal:  Eur Urol       Date:  1999-11       Impact factor: 20.096

7.  Validation of Randall's plaque theory using unenhanced abdominal computed tomography.

Authors:  Alexandru Ciudin; Maria Pilar Luque Galvez; Rafael Salvador Izquierdo; Mihai Gabriel Diaconu; Agustin Franco de Castro; Vlad Constantin; Jose Ricardo Alvarez-Vijande; Carlos Nicolau; Antonio Alcaraz Asensio
Journal:  Urology       Date:  2013-02       Impact factor: 2.649

8.  Urea-nitrogen production and salvage are modulated by protein intake in fed humans: results of an oral stable-isotope-tracer protocol and compartmental modeling.

Authors:  Hélène Fouillet; Barbara Juillet; Cécile Bos; François Mariotti; Claire Gaudichon; Robert Benamouzig; Daniel Tomé
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

Review 9.  Investigation of single and recurrent stone formers.

Authors:  H G Tiselius
Journal:  Miner Electrolyte Metab       Date:  1994

10.  Association between Randall's plaque and calcifying nanoparticles.

Authors:  Neva Ciftçioğlu; Kaveh Vejdani; Olivia Lee; Grace Mathew; Katja M Aho; E Olavi Kajander; David S McKay; Jeffrey A Jones; Marshall L Stoller
Journal:  Int J Nanomedicine       Date:  2008
View more
  5 in total

Review 1.  The association of metabolic syndrome and urolithiasis.

Authors:  Yee V Wong; Paul Cook; Bhaskar K Somani
Journal:  Int J Endocrinol       Date:  2015-03-22       Impact factor: 3.257

Review 2.  Recent advances in understanding and managing urolithiasis.

Authors:  Walter L Strohmaier
Journal:  F1000Res       Date:  2016-11-08

3.  Association between chronic pancreatitis and urolithiasis: A population-based cohort study.

Authors:  Chien-Hua Chen; Cheng-Li Lin; Long-Bin Jeng
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

Review 4.  Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.

Authors:  Giovanni Gambaro; Emanuele Croppi; Fredric Coe; James Lingeman; Orson Moe; Elen Worcester; Noor Buchholz; David Bushinsky; Gary C Curhan; Pietro Manuel Ferraro; Daniel Fuster; David S Goldfarb; Ita Pfeferman Heilberg; Bernard Hess; John Lieske; Martino Marangella; Dawn Milliner; Glen M Preminger; Jose' Manuel Reis Santos; Khashayar Sakhaee; Kemal Sarica; Roswitha Siener; Pasquale Strazzullo; James C Williams
Journal:  J Nephrol       Date:  2016-07-25       Impact factor: 3.902

5.  Relationship of endoscopic lesions of the renal papilla with type of renal stone and 24 h urine analysis.

Authors:  X A Sabaté Arroyo; F Grases Freixedas; J L Bauzà Quetglas; J Guimerà Garcia; E Pieras Ayala
Journal:  BMC Urol       Date:  2020-04-25       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.